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StressOpioids are among the world's oldest known drugs used mostly for pain relief, but recreational use is also
widespread. A particularly important problem is opioid exposure in females, as their offspring can also be affected.
Adverse intrauterine and postnatal environments can affect offspring development and may lead to various
disabilities later in life. It is clear that repetitive painful experiences, such as randomly occurring invasive proce-
dures during neonatal intensive care, can permanently alter neuronal and synaptic organization and therefore
later behavior. At the same time, analgesic drugs can also be harmful, inducing neuronal apoptosis or withdrawal
symptoms in the neonate and behavioral alterations in adulthood. Hence, risk–beneﬁt ratios should be taken into
consideration when pain relief is required during pregnancy or in neonates.
Recreational use of opioids can also altermany aspects of life. Intrauterine opioid exposure hasmany toxic effects,
inducing poor pregnancy outcomes due to underdevelopment, but it is believed that later negative consequences
are more related to environmental factors such as a chaotic lifestyle and inadequate prenatal care. One of the
crucial components is maternal care, which changes profoundly in addicted mothers. In substance-dependent
mothers, pre- and postnatal care has special importance, and controlled treatment with a synthetic opioid
(e.g., methadone) could be beneﬁcial.
We aimed to summarize and compare human and rodent data, as it is important to close the gap between
scientiﬁc knowledge and societal policies. Special emphasis is given to gender differences in the sensitivity of
offspring to perinatal opioid exposure.
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Opiates are drugs derived from opium (e.g., morphine, heroin,
codeine), a powdered dried exudate of the fruit capsule (poppy) of
the plant Papaver somniferum, that act on opioid receptors in our body.
Opioids are among the world's oldest known drugs; archeological
evidence and fossilized poppy seeds suggest that Neanderthals may
have used these drugs over thirty thousand years ago (Rosenfeld and
Loose, 2007). The drugs' main effect is to relieve pain, so they are pow-
erful analgesics. Furthermore, opioids are well known for their ability
to produce euphoria, motivating certain individuals to engage in recre-
ational use.
The potential danger of most opioids is that prolonged use results in
physical and psychological dependence (Kaltenbach, 1996). According
to a study published in The Lancet (Kapp, 2003), heroin is the most
dangerous drug among those studied based on its physical harm to
the user, addictive potential and overall negative impact on society. In
2010, there were reportedly as many as 2.4 million people in the
United States (US) with an opioid problem (Rockville, 2011). However,
the majority of opioids used in the US originate from a legal doctor's
prescription written to treat pain.
A particularly important problem is the use of opioid drugs (both
painkillers and “street drugs”) in females, as these drugsmay also inﬂu-
ence offspring. Similar to many abused drugs, morphine can cross the
placenta and blood–brain barrier and even exudes into the breast
milk. Opioid receptors are present in several areas of the brain, and
multiple mechanisms can be affected by opiate exposure (Yanai et al.,
2003). Based on data averaged across 2010 and 2011 in the US, among
pregnant women (15–44 years old), 5% were current illicit drug users
(Rockville, 2012). Rats are used extensively to study the developmental
effects of opiates because many of their responses to drugs resemble
those of humans (Bashore et al., 1981). However, there is a gap between
rodent-based scientiﬁc knowledge and societal policies (Thompson
et al., 2009).
We aimed to review the effect of opioid treatment/use on offspring,
comparing human and rodent studies, with the goal of identifying the
gaps between the two study types. We follow a “chronological” order,
from preconceptional effects to intrauterine treatments and treatments
during labor to the early and late consequences of postnatal administra-
tion, with special emphasis on possible gender differences.
Preconceptional use
Human studies
It is known that preconceptional effects can profoundly alter later
pregnancy and the fetus (Twigt et al., 2012). Despite this fact, in
humans, the pregnancy rate is not inﬂuenced by injection drug (such
as heroin) use (Weber et al., 2003). We must mention, however, that
low uptake of reliable contraception can confound the results.
Animal studies
Appropriate usage of morphine can be beneﬁcial in enhancing the
pregnancy rate, based on a study using embryo transfer in rats (Smith
et al., 2004). In rodents, a premating morphine exposure regimen
(prior to pregnancy) had no effect on maternal behavior (Yim et al.,
2006; Johnson et al., 2011) but induced long-term effects in offspring.
In line with this ﬁnding, the female offspring of dams exposed to
morphine during puberty displayed increased anxiety-like behaviorPlease cite this article as: Fodor A, et al, Behavioral effects of perinatal opioiboth in the elevated plus-maze (EPM) and in a novel environment,
possibly due to altered prolactin regulation (Byrnes, 2005a). The male
offspring of females exposed to morphine during adolescence showed
alteration in their early social playing behavior (Johnson et al.,
2011). Thus, there is a transgenerational effect of opioid exposure,
with gender-speciﬁc alterations (Slamberova et al., 2005).
Prenatal exposure
Human studies
Among the opioids, heroin, methadone and buprenorphine (the last
two are synthetic opioids used as anti-addictive maintenance prepara-
tions) are the forms most commonly used by pregnant women
(Bhuvaneswar et al., 2008). Opioids undergo rapid transplacental
passage (less than 60 min), and maternal and fetal withdrawal is likely
to begin 6–48 h after the last use (Bhuvaneswar et al., 2008).
Pregnancy complications, including premature rupture of themem-
branes, meconium-stained liquor and fetal distress, are more common
in women who misuse drugs (Johnson et al., 2003). The incidence of
stillbirths and neonatal mortality in addicts is 2–4 times higher than
that in the general population (Lam et al., 1992). Moreover, sudden
infant death syndrome is seven times more frequent in the children of
addicts than in the normal population. The principal causes of infant
death are prematurity and growth retardation (Bashore et al., 1981).
In a Chinese population, babies born to drug-addicted mothers were
on average 629 g lighter at birth, 5 cm smaller in head circumference
and 7 cm shorter in body length (Lam et al., 1992). Adverse conse-
quences are associated with many incremental social, psychosocial
and contextual factors, such as a chaotic lifestyle, incomplete nutrition,
intrauterine infections and inadequate prenatal care (Schempf, 2007).
In fact, 75% of pregnant heroin addicts do not receive any prenatal
care (Bashore et al., 1981).
Methadone treatment during pregnancy offers overwhelming
advantages compared with the less acceptable option of medical
detoxiﬁcation or the unacceptably dangerous option of leaving heroin-
addicted women dependent on street drugs (Kandall et al., 1999). The
Maternal Opioid Treatment: Human Experimental Research (MOTHER)
project found both methadone and buprenorphine to be important
parts of a comprehensive treatment approach (Jones et al., 2012a,
2012b). Many studies examining neonatal outcomes among pregnant
heroin users treated with methadone have reported improvements in
birth weight (Strauss et al., 1974; Kandall et al., 1975). Therefore,
methadone treatment has become the ‘gold standard’ for management
of the pregnant heroin user. However, subsequent studies have
suggested that heroin use while receiving methadone may counteract
the birth weight advantage gained from methadone alone (Hulse
et al., 1997), but this phenomenon may be connected to the chaotic
and high-risk lifestyle of users as well (Hulse et al., 1998). Further
studies are required to identify important factors related to drug use
(e.g., social circumstances, poor nutrition, stress, infections). Inﬂuencing
these factors will be beneﬁcial to improving neonatal outcomes
(Schempf, 2007).
Neonatal abstinence syndrome (NAS), or withdrawal symptoms,
occur in 55–94% of neonates exposed to opiates in utero, without a
signiﬁcant difference between male and female infants (Holbrook and
Kaltenbach, 2010). Commonly observed symptoms include irritability,
high-pitched crying, tremors, hypertonicity, vomiting, diarrhea and
tachypnea (Johnson et al., 2003). The onset of signs attributable to
neonatal withdrawal from heroin often begins within 24 h of birth,d exposure, Life Sci (2014), http://dx.doi.org/10.1016/j.lfs.2014.04.006
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over a certain numerical threshold on abstinence tests are treated
with medication (Jansson et al., 2009). The goal of medication therapy
is the stabilization of more severely symptomatic infants, allowing
them to eat, sleep, gain weight and interact with caregivers. However,
the pharmacologic management of NAS remains a challenge. Opioid
agonist medications are thought to be the most effective agents in the
treatment of neonatal neurobehavioral problems related to in utero
opioid exposure. In 2005, the Cochrane Review failed to identify a
speciﬁc opioid as optimal for the treatment of infants undergoing opioid
withdrawal (Osborn et al., 2005). A later review, published in 2011,
suggested oral morphine solutions as the mainstay of NAS therapy
(Bio et al., 2011).
Later consequences of in utero opioid exposure have also been
described in humans. Inattention, hyperactivity, impulsivity and aggres-
sion, the major diagnostic criteria of attention deﬁcit hyperactivity
disorder (ADHD), are known to persist into adulthood in children
born to heroin-dependent mothers or to mothers using methadone
during pregnancy (Ornoy et al., 1996). One of themajor factors affecting
the development of these children is the environment inwhich they are
raised (Ornoy et al., 1996, 2001; Weisglas-Kuperus et al., 1993). Among
children born to heroin-dependentmothers raised by adoptive families,
hyperactivity was found in a signiﬁcantly lower percentage than among
children exposed to heroin in utero and raised by their biological
families.
Nevertheless, the effects of prenatal exposure to drugs on brain
development are complex and are modulated by the timing, dose and
route of drug exposure (Thompson et al., 2009). Therefore, it is difﬁcult
to assess these effects in clinical cohorts, which are beset with problems
such as difﬁculties in documenting use patterns (Jones et al., 2012a).
Thus, animal studies are required.
Animal studies
The immature brain seems to be particularly vulnerable to the
actions of opiates (Bashore et al., 1981). Opiates appear to selectively
accumulate in the nervous tissues of offspring because of increased
permeability of the blood–brain barrier andmay affect the development
of the central nervous system (CNS) and cause a variety of delays in
ontogeny (Peters et al., 1972; Shah and Donald, 1979). Similar to
observations in humans, the administration of opiates during fetal de-
velopment may result in increased intrauterine death, therebyTable 1
A summary of behavioral consequences of prenatal opioid exposure in rodent models.
Behavioral alteration Tests Difference
Motor coordination Postnatal reﬂexes Slightly reduced
Spontaneous activity Reduced on PND1,
Anxiety Novel environment Anxiogenic
Open ﬁeld No alteration
Elevated plus maze Anxiogenic
Startle response Enhanced in male,
Depression Forced swim test Depression-like
Saccharin preference Enhanced
Learning Symmetrical maze Faster learning in m
Passive avoidance Impaired
Memory Eight-arm radial maze Memory decline mo
Drug sensitivity Active and passive avoidance Enhanced
Pain Reduced antinocice
Analgesia Hot plate Enhanced sensitivit
Tail-ﬂick Reduced tolerance
of morphine
Sexual behavior Inhibition in female
Drug seeking Conditioned place preference Enhanced
Maternal behavior Spontaneous Decreased
Vs. insect hunting Maternal care decre
The different studies used different treatment protocols. It is obvious, thatmany alterations can b
be detected in both sexes. PND— postnatal day.
Please cite this article as: Fodor A, et al, Behavioral effects of perinatal opioidecreasing litter size, in rodents (Fujinaga and Mazze, 1988). Although
no teratogenic effects were observed with the chronic administration
of morphine in one study, the number of stillbirths and infant mortality
increased, and the body growth of the offspring of drug-exposed female
rats was stunted (Zagon and McLaughlin, 1977). Fetal exposure to
opiates may adversely affect the migration and survival of neurons in
rat embryos, thereby leading to an overall inhibition of brain growth
and development during this critical period of CNS development
(Vathy, 1995; Walhovd et al., 2009). Exposure to opiates prenatally
can alter opioid receptor density and distribution. This phenomenon
can in turn affect the development of neural connections by delaying
or accelerating neural outgrowth. Indeed, heroin exposure in pregnant
mice decreased dendrite length and branch numbers in pyramidal
neurons in the somatosensory cortex of offspring (Lu et al., 2012).
Later consequences of intrauterine drug exposure have been exten-
sively studied in rodents (Table 1). Our owndata also support long-term
consequences in the offspring of morphine-exposed mothers (from the
day ofmatinguntilweaning) (Klausz et al., 2011). The persisting somatic
changes (Fig. 1) included body and adrenal gland weight decreases,
which were a sign of disturbed stress-axis regulation, and altered
blood glucose levels (Fig. 3D) (Castellano and Ammassari-Teule, 1984).
Changes in motor development and analgesia have also been described
(Castellano and Ammassari-Teule, 1984; Eriksson and Ronnback, 1989;
Gagin et al., 1996; Robinson and Wallace, 2001). Adult mice that
underwent prenatal heroin exposure showed certain signs of impaired
short-term spatial memory (Lu et al., 2012). Prenatal morphine
exposure may result in enhanced activity and/or sensitivity of the
endogenous opiate system, thereby placing the organism at higher risk
of opiate drug addiction (Gagin et al., 1997a; Timar et al., 2010; Sobor
et al., 2010). Indeed, Ramsey et al. found that prenatal morphine expo-
sure enhanced the reinforcing effects of heroin and cocaine, asmeasured
by self-administration (Ramsey et al., 1993). Prenatal morphine treat-
ment also has an age-dependent effect on seizure susceptibility, which
is highly inﬂuenced by gonadal hormones, with males being more
vulnerable than females to morphine-induced insults during prenatal
brain development (Vathy, 2001; Vathy et al., 1998; Slamberova and
Vathy, 2000; Schindler et al., 2000; Velisek et al., 1998). As a possible
explanation, mu-opioid receptors in seizure-controlling brain structures
are sex-speciﬁcally altered by prenatal morphine exposure in adult
progeny (Slamberova et al., 2002).
There is gender dimorphism in the rodent brain (Vathy, 1995), as
prenatal morphine exposure reduces female sexual behavior but doesReference
Castellano and Ammassari-Teule (1984)
no difference in adult Castellano and Ammassari-Teule (1984)
Byrnes (2005a), Timar et al. (2010)
Hamilton et al. (2005)
Byrnes (2005a), Klausz et al. (2011)
no change in female Hamilton et al. (2005)
McPherson et al. (2007), Klausz et al. (2011)
Gagin et al. (1996)
ales but not females Slamberova et al. (2001a)
McPherson et al. (2007)
stly in females Slamberova et al. (2001a)
Castellano and Ammassari-Teule (1984)
ptive morphine effect Timar et al. (2010)
y to morphine Eriksson and Ronnback (1989), Gagin et al. (1996)
to antinociceptive effect Gagin et al. (1996), Robinson and Wallace (2001),
Sobor et al. (2010), Timar et al. (2010)
, no alteration in male Vathy et al. (1983, 1985, 1999), Gagin et al. (1997b)
Timar et al. (2010), Sobor et al. (2011)
Moura et al. (2010), Sobor et al. (2010, 2011)
ased Cruz Ade et al. (2010)
e found after perinatal opioid exposure, however,most of the changes aremild and cannot
d exposure, Life Sci (2014), http://dx.doi.org/10.1016/j.lfs.2014.04.006
Fig. 1. Effects of maternal morphine exposure (from the day of mating until weaning, 10 mg/ml/kg subcutaneously) on body weight (A), the adrenal glands (B) and spleenweight (C) in
adult male and female offspring. For method details, see Klausz et al. (2011). N= 10–14. (A) Bodyweight (g) was smaller in female rats (p b 0.05), andmorphine treatment signiﬁcantly
reduced this parameter for a prolongedperiod (p b 0.05). (B) Theweight of both adrenal glandswashigher in females (p b 0.01),with a reduction inmaternallymorphine-treated animals
(p b 0.01). (C) The weight of the spleen showed an interaction between gender and treatment (p b 0.05), with a lower weight in females and a high value in females among morphine-
treated animals. *p b 0.05 vs. control treatment; #p b 0.05 vs. male.
4 A. Fodor et al. / Life Sciences xxx (2014) xxx–xxxnot have a profound effect on males (Vathy et al., 1985). Adult sexual
behavior in female rats is both defeminized and masculinized (Vathy,
1999; Gagin et al., 1997b). The inhibition of female sexual behavior
(Vathy et al., 1983) is contrasted by enhanced social play during their
juvenile age,most likely due to an inﬂuence onmotivational and reward
systems (Niesink et al., 1996). Our results showed similar dimorphism.
The weight of the spleen, reﬂecting immune function, changed in the
opposite manner in males and females (Fig. 1C). As susceptibility
to mental illnesses is most likely to change (Fumagalli et al., 2007;Fig. 2. Effects of maternal morphine exposure (from the day of mating until weaning, 10 mg/m
open/total entries (B) and number of closed arm entries (C)) and forced swim test (FST) (% of
offspring. For the details of the method, see Klausz et al. (2011). N= 12. Anxiety-like behavior
enhanced closed armentries (C; p= 0.05), butmorphinepretreatment did not have a similar ef
in females (A, B). Depressive-like behavior was tested in the FST (D, E). As a sign of a more depr
(D; p b 0.05). There was an interaction between gender and treatment in the case of struggl
treatment; #p b 0.05 vs. male.
Please cite this article as: Fodor A, et al, Behavioral effects of perinatal opioiMaccari et al., 2003), we studied mood-relevant behaviors. This exami-
nation of anxiety- and depression-like behavior revealed a signiﬁcant
gender–treatment interaction (Fig. 2). In our case, male offspring were
more vulnerable to the anxiogenic and depressogenic effects of
intrauterine and postnatal morphine treatment than were females
subjected to the EPM and the forced swim test (FST) (Klausz et al.,
2011). Similarly, Hamilton and coworkers reported an elevated startle
response in the male, but not female, offspring of morphine-treated
mothers (Hamilton et al., 2005). Additionally, Slamberova et al.l/kg subcutaneously) on elevated plus-maze (EPM) (% of open arm time (A), number of
ﬂoating time (D) and time spent in struggling (E)) performance in adult male and female
was measured in the EPM for 5 min (A–C). Female rats weremore active, as suggested by
fect. Treatedmale rats had ananxiogenic phenotype,whereas pretreatmentwas ineffective
essive-like phenotype, the time spent ﬂoating was enhanced inmorphine-treated animals
ing behavior, as the male rats were more vulnerable (E; p = 0.05). *p b 0.05 vs. control
d exposure, Life Sci (2014), http://dx.doi.org/10.1016/j.lfs.2014.04.006
5A. Fodor et al. / Life Sciences xxx (2014) xxx–xxxdemonstrated that prenatal morphine exposure differentially altered
the performance of adult male and female rats on tasks requiring learn-
ing and spatial memory (Slamberova et al., 2001a). Another group re-
ported disturbance in a passive avoidance retention task in females
after intrauterine morphine treatment (Degos et al., 2012). We found
a signiﬁcant gender–treatment interaction in the case of stressor-
induced blood glucose elevation as well (Fig. 3D).
Dysregulation of the stress axis, and especially alteration in
glucocorticoid levels, is a core feature of mood disorders (Joels, 2011).
Therefore, it is important to note that prenatal opiate exposure followed
by postnatal withdrawal diminished the stress axis response to immu-
nological and social stressors in neonatal rats, whereas in adulthood,
an exaggerated response was detected (Hamilton et al., 2005). The
adrenocorticotropin (ACTH, the hypophyseal component of the stress
response) and corticosterone (a rodent glucocorticoid in the adrenal
cortex) responses are dissociated (Rimanoczy et al., 2003; Slamberova
et al., 2004). Although there were no differences in basal levels between
control animals and intra- and postnatal morphine-treated animals,
stressor-induced ACTH elevations were smaller in the opioid-exposed
groups. In addition to glucocorticoid regulation, ACTH has many differ-
ent effects (Zelena and Makara, 2012). Nevertheless, as the end hor-
mones of the axis are glucocorticoids, we are concentrating on these
molecules. In our study, resting glucocorticoid levels were elevated in
the adult male offspring of morphine-treated dams (among females,
the higher basal levels of untreated animals masked any elevation),
suggesting chronic stress-like changes (Fig. 3A). FST-induced changesFig. 3. Effects of maternal morphine exposure (from the day of mating until weaning,
10 mg/ml/kg subcutaneously) on serum corticosterone and blood glucose changes:
(A, C) basal values and (B, D) after acute stress (5 min FST) in adult male and female
offspring. For the details of the method, see Klausz et al. (2011). N = 12. (A) Under
basal conditions, female rats had higher corticosterone levels (p b 0.01), and morphine
pretreatment was able to induce a further increase only in males. (B) At the end of a
5 min challenge, females showed much higher levels (p b 0.01). However, maternal
morphine treatment diminished the elevation in both genders (p b 0.01). (C) Resting
blood glucose levels were lower in morphine-treated animals (p = 0.05), with more
severe changes in females. (D) Stressor exposure induced a smaller increase in females
(p b 0.01).*p b 0.05 vs. control treatment; #p b 0.05 vs. male.
Please cite this article as: Fodor A, et al, Behavioral effects of perinatal opioiwere smaller in morphine-treated groups of both genders (Fig. 3B).
The disturbed stress axis suggested damaged adaptive capability
(Klausz et al., 2011). Accordingly, we found smaller stress-related
organs (Fig. 1B), hypoactivity of the stress axis (Fig. 3B) and enhanced
depression-like behavior during the FST (Fig. 2D, E), and males were
at greater risk than females were.
There must be a certain optimum level of opioids, as not only the
enhanced activation of their receptors by agonists but also intrauterine
and postnatal antagonist exposure (a naltrexone implant is used
clinically for people wanting to abstain from opiates and/or alcohol)
may induce aversive effects. Although no major adverse neonatal out-
comes have been found with respect to birth weight, Apgar score or
head circumference (Hulse et al., 2001), long-term follow-up showed
reduced locomotor activity, enhanced psychomotor sensitization to
morphine and elevated drug-seeking behavior in the adult offspring of
naltrexone-treated rat dams (Farid et al., 2012).
Maternal behavior in animals
Based on human studies (Ornoy et al., 1996), we cannot rule out the
possibility that the above-mentioned late consequences were an
indirect result of morphine-induced alterations in maternal physiology
and/or behavior. Although prematingmorphine treatment had no effect
(see earlier), treatment during lactation can profoundly inﬂuence the
mother's behavior. It is known that inadequate maternal care results
in altered behavioral and endocrine responses to stress in offspring
(Levine, 2005; Weaver et al., 2004).
Plasma and brain levels of endogenous opioids increase over
the course of pregnancy, peak during parturition and then decline to
pre-pregnancy levels during lactation (Petraglia et al., 1985; Wardlaw
and Frantz, 1983). These changes in endogenous opioids are consistent
with “pregnancy-mediated analgesia”, an elevation in the pain threshold
(hypoalgesia) during labor and delivery (Gintzler, 1980). Additionally,
systemically administered exogenous opiates inhibitmaternal behavior
in lactating dams (Sobor et al., 2010; Bridges and Grimm, 1982;
Slamberova et al., 2001b). Non-sedative doses of morphine disrupt
(e.g., increase the latency to retrieve pups) and naloxone restores
maternal responsiveness in female rats (Bridges and Grimm, 1982;
Haney and Miczek, 1989). During prolonged administration, sensitiza-
tion also occurs, meaning that maternal behavior may be inhibited by
low doses of morphine (e.g., 3 mg/kg) that are otherwise ineffective
at inducing such inhibition in control lactating rats (in which at least
5 mg/kg is needed) (Sobor et al., 2010; Miranda-Paiva et al., 2001;
Cruz Ade et al., 2010). Moreover, the rewarding potential of morphine
increases in treated dams, measured on conditioned place preference
(Sobor et al., 2011). Not only is spontaneous maternal care reduced
but behavioral selection between pup care and insect hunting also
shifted to the latter direction (Cruz Ade et al., 2010). Late pregnancy
was particularly sensitive in terms of morphine's effects on maternal
behavior (Yim et al., 2006).
Vathy et al. studied the later consequences of disrupted maternal
care by morphine-treated mothers for offspring (Vathy et al., 2007).
The researchers found that disrupted maternal behavior was more
important than prenatal drug exposure itself in rewarding cocaine
self-administration in adulthood, especially in female offspring.
However, the late consequences of the in utero morphine exposure
of female offspring were opposite to the consequences of the acute
maternal effects. In particular, when these offspring became mothers,
their active nursing behaviorwas increased; theywere faster in carrying
the ﬁrst pup, returning the ﬁrst pup to the nest and returning all pups to
the nest (Slamberova et al., 2003).
Opioid exposure during labor in human studies
Reynolds hypothesized that neuraxial analgesia is the worst type
of analgesia for babies because of negative maternal changesd exposure, Life Sci (2014), http://dx.doi.org/10.1016/j.lfs.2014.04.006
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(Reynolds, 2011). However, the fetal stress response to labor, resulting
in a conspicuous catecholamine surge, is beneﬁcial for adaptation to
extrauterine life. Nevertheless, pain relief during childbirth is very
common, so we have a large amount of human data.
Fentanyl (a synthetic opioid analgesic) is a frequently used, highly
lipid soluble drug that would be expected to cross the placenta easily
and to rapidly equilibrate between the maternal and the fetal circulation.
However, the use of continuous-infusion epidural analgesia with low-
dose bupivacaine and fentanyl over periods of up to 15 h during labor
did not result in signiﬁcant drug accumulation in either the mother or
the neonate (Bader et al., 1995). Despite this fact, later consequences of
opioid use during laborwere present. Babies delivered after theirmothers
received N300 μg fentanyl during the last 4 h of labor may be at greater
risk of respiratory depression (Kumar and Paes, 2003). Moreover, infants
whosemothers received 80 μg sufentanil showmild neurobehavioral de-
pression (Capogna et al., 1989). Several types of analgesia given to the
mother during labor may interfere with the newborn's spontaneous
breast-seeking and breastfeeding behaviors and increase the newborn's
temperature and crying (Ransjo-Arvidson et al., 2001).
Newborn exposure
Via the mother
Human data
Milk production is a mammalian characteristic and is of particular
importance for humans. In addition to their well-known nutritive role,
milk constituents can carry speciﬁc information (Teschemacher et al.,
1997). Thus, a number of milk protein fragments have been shown
to behave as opioid receptor ligands. Most of these fragments have
agonistic properties, and beta-casomorphins have known functional
signiﬁcance (Teschemacher and Koch, 1991). These peptides are impli-
cated in a number of medical conditions, including diabetes, heart
disease and symptoms of autism and schizophrenia, although the
currently available data are inadequate to guide treatment recommen-
dations (e.g., to eliminate the origin of casomorphin, casein, from the
diet) (Christison and Ivany, 2006).
Recreational use of opioids exclusively during lactation is rare.
However, maternal painkillers may have an effect on offspring. It is
well documented that one of the overlooked effects of opiate use is an
opiate-mediated elevation in the secretion of prolactin (Byrnes,
2005b). This elevation may lead to better milk production, which may
partly compensate for harmful outcomes. In line with this observation,
in one study, post-cesarean analgesia with epidural morphine had a
relatively positive effect on offspring, whoweremore alert and oriented
to animate human cues (Wittels et al., 1997).
Animal studies
Despite the possible positive effects in humans, Timar et al. found that
in rats postnatal exposure tomorphine throughmaternalmilk resulted in
slower weight gain and inmales impaired habituation to a new environ-
ment (Timar et al., 2010). Moreover, the female offspring of morphine-
treated lactating rat mothers (postnatal days (PNDs) 1–21) failed in a
passive avoidance retention task (Nasiraei-Moghadam et al., 2013).
Direct infant exposure
Therapeutic usage in humans
Both neonates and infants are able tomount a graded hormonal stress
response to surgical interventions. Adequate intra- and postoperative an-
algesia not onlymodiﬁes the stress response but also has been shown to
reduce morbidity and mortality (Lonnqvist and Morton, 2005). Repeti-
tive untreated pain and distress may impair the premature brain and
have short- and long-term negative consequences (Duhrsen et al.,
2013;Walker, 2014). For example, the effects of neonatal inﬂammatoryPlease cite this article as: Fodor A, et al, Behavioral effects of perinatal opioipain resulted in decreased locomotor activity in adult rats, and this ef-
fect was reduced by morphine pretreatment (Bhutta et al., 2001).
Therefore, pain management is increasingly recognized as an integral
part of the effective management of vulnerable babies in the neonatal
intensive care unit (NICU) (Walker, 2014; Hall, 2012). Beyond the
most common non-pharmacologic techniques (sucking, maternal con-
tact andmassage), the drugs used to treat neonatal pain include opiates.
Nevertheless, opioid use poses a certain risk. The neuraxial adminis-
tration of opioids may induce respiratory depression and increase the
number of secondary medical interventions (due to postoperative
nausea and vomiting, urinary retention and pruritus and decreased
recovery of gastrointestinal function) (Hall, 2012; Lonnqvist et al.,
2002). Morphine premedication for intubation leads to prolonged
(24 h) electroencephalogram (EEG) depression, so this treatment is
not recommended for short interventions (Norman et al., 2013). A
high dose of opioids may induce EEG spikes, although behavioral
convulsions are only rarely detected (van Praag and Frenk, 1992). Addi-
tionally, placebo-controlled trials in ventilated neonates found that
fentanyl reduced stress hormones (catecholamines and glucocorti-
coids), episodes of hypoxia and behavioral stress scores but increased
ventilation requirements (Anand and Hall, 2006). Moreover, morphine
seems to provide adequate sedation and analgesia during hypothermia
for the treatment of neonatal asphyxial encephalopathy (Roka et al.,
2008). Taken together, several studies and reviews (e.g., Cochrane
Reviews) have concluded that opiates should be used selectively in
NICU newborns (Bellu et al., 2010).
Experimental conditions in rodents
Postnatal morphine administration may have negative effects on
somatic development (including body growth and eye and vaginal
opening development) (Zimmerman et al., 1977) and on neuronal
growth in the developing animal (Hammer et al., 1989). Rozisky et al.
observed that morphine treatment in early life in newborn male rats
modulates brain-derived neurotrophic factor (BDNF) levels in the
hippocampus (Rozisky et al., 2013). These changesmay underlie behav-
ioral alterations. Indeed, early postnatal exposure to morphine signiﬁ-
cantly decreased the ultrasonic vocalization of rat pups removed from
their nest, serving as a marker of behavioral development (Cuomo
et al., 1988). Moreover, repeated neonatal morphine injections in rats
impaired passive avoidance learning and altered FST behavior in adult-
hood (McPherson et al., 2007).
Intraplantar formalin-induced pain reactions were reduced by acute
morphine treatment in neonates (Abbott and Guy, 1995). However,
when the postnatal morphine administration was followed by 4 days
of abstinence, the pain reaction increased signiﬁcantly (Zissen et al.,
2006). Similarly, antinociceptive tolerance to morphine administration
developed, as measured by a hot plate test (Bajic et al., 2013). In these
cases, brain region-speciﬁc apoptosis occurred in unaffected glial cells,
serving as a possible background mechanism (Bajic et al., 2013).
Controversially, the postnatal treatment of male rats with morphine
reduced the development of pentylenetetrazol (PTZ)-induced seizures
and the mortality rate in adulthood, possibly through the activation of
GABAergic neurons in the hippocampus (Saboory et al., 2014). This
effect was very similar to the consequences of prenatal morphine treat-
ment, with decreased susceptibility to GABA-regulated seizures (Vathy,
2001). Additionally, morphine treatment may protect the developing
brain from severe pain-induced pathological changes, although only
under certain conditions (Duhrsen et al., 2013). Postnatal morphine
treatment results in enhanced tail ﬂick latency and a reduced ethanol
preference, suggesting an additional positive impact (Duhrsen et al.,
2013).
Conclusions
The most common perinatal usage of opioids is for medical
purposes, mostly in the form of a single or short-term treatment, andd exposure, Life Sci (2014), http://dx.doi.org/10.1016/j.lfs.2014.04.006
7A. Fodor et al. / Life Sciences xxx (2014) xxx–xxxthe main reason is to relieve pain. There is compelling evidence that an
adverse intrauterine and postnatal environment can affect offspring's
development and potentially lead to various learning, behavioral and
mood disorders and to complex diseases, such as obesity and cardiovas-
cular conditions, later in life (Schuurmans and Kurrasch, 2013; Rinaudo
and Lamb, 2008; Viltart and Vanbesien-Mailliot, 2007). In particular,
susceptibility to mental illnesses can increase (Fumagalli et al., 2007;
Maccari et al., 2003). It is clear that repetitive painful experiences,
such as randomly occurring invasive procedures and handling during
neonatal intensive care, can permanently alter neuronal and synaptic
organization and therefore later behavior (Anand, 2000). At the same
time, analgesic drugs can be harmful, as morphine has been found to
increase apoptosis in human fetal microglia and neurons (Hu et al.,
2002). Whereas the short-term consequences of prolonged analgesic
therapy in human neonates are well-known (tolerance, withdrawal
andventilator dependency), their long-term consequences are relatively
unknown; animal studies suggest negative outcomes. Therefore, risk–
beneﬁt ratios should always be taken into considerationwhen pain relief
is required in pregnant women or in neonates.
Recreational use of opioids can also alter many aspects of perinatal
life; even the probability of conception may be disturbed. Intrauterine
opioid exposure hasmany toxic effects (see above), leading to poor preg-
nancy outcomes, including underdevelopment, but it is believed that
later negative consequences (Table 1) are more related to negative envi-
ronmental factors (Ornoy et al., 1996; Weisglas-Kuperus et al., 1993).
One of the crucial components is the disturbance of maternal care,
which changes profoundly in substance-using mothers. Interventions
will need to address the factors surrounding drug use to greatly improve
neonatal outcomes (e.g., social circumstances, poor nutrition, stress, in-
fections) (Schempf, 2007). Nevertheless, there is a certain optimum
level of opioids, as not only opioid agonists but also antagonists have
been shown to have long-term negative impacts (Farid et al., 2012). In
dependentmothers, pre- and postnatal care initiation by society has spe-
cial importance, and controlled treatment with a synthetic opioid (e.g.,
methadone or buprenorphine) could be beneﬁcial (Kandall et al., 1999).
It is important to close the gap between scientiﬁc knowledge and
societal programs for at-risk populations (Thompson et al., 2009;
Walhovd et al., 2009). More emphasis should be given to disseminating
scientiﬁc knowledge, enlightenment and prevention.
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